Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2811.00x is in line with its 1-year average of -2797.59x, near the low end of its 1-year range (-2811.00x–-2784.18x).
As of the fiscal period ended Tuesday, June 30, 2026. 0.48% below its 12-month average of -2797.59x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -2811.00x.
INTEREST COVERAGE RATIO
-2811.00x
INTEREST COVERAGE RATIO AVG TTM
-2797.59x
INTEREST COVERAGE RATIO AVG 3Y
-2797.59x
INTEREST COVERAGE RATIO AVG 5Y
-2797.59x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.48%
CURRENT VS 3Y AVG
-0.48%
CURRENT VS 5Y AVG
-0.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 454 covered companies
CURRENT VS SECTOR MEDIAN
-49740.40%
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$477.27M
Interest Coverage Ratio
-2811.00x
TTM Avg
-2797.59x
3Y Avg
-2797.59x
5Y Avg
-2797.59x
Market Cap
$475.46M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$474.22M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.48M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
Market Cap
$486.85M
Interest Coverage Ratio
5.63x
TTM Avg
4.06x
3Y Avg
3.16x
5Y Avg
2.54x
Market Cap
$462.12M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$498.55M
Interest Coverage Ratio
-99.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $477.27M | -2811.00x | -2797.59x | -2797.59x | -2797.59x |
| Arvinas, Inc. (ARVN)vs › | $478.75M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $475.46M | -1.04x | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.22M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $472.48M | 30.36x | 30.37x | 18.36x | 29.15x |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.85M | 5.63x | 4.06x | 3.16x | 2.54x |
| Evolus, Inc. (EOLS)vs › | $491.28M | -1.91x | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $462.12M | 4.74x | 9.15x | 25.82x | 26.16x |
| Oculis Holding AG (OCS)vs › | $498.55M | -99.49x | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $451.59M | N/A | N/A | N/A | N/A |
Interest Coverage
-2811.0x
Debt/Equity
0.00
Current Ratio
121.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2811.00x |
| 2026-03-31 | -2784.18x |
| 2020-12-31 | -35.86x |
